Inam Butt and the Lenient Doping Case: When 'Eye Medication' Still Costs an Asian Beach Games Silver

Last April, a sample collected at the Asian Beach Games named Inam Butt — Pakistan's former beach wrestling world champion. The substance detected was not anabolic steroid, not growth hormone, and not any stimulant typically seen in doping headlines. It was a medication used to treat an eye condition. But within WADA's World Anti-Doping Code, the line between 'therapeutic medicine' and 'prohibited substance' does not sit at the purpose of use. It sits at the moment the athlete files for a Therapeutic Use Exemption (TUE). Inam Butt is not being treated as a cheater. But his name may still be erased from the record books. In anti-doping files, there is a paradox fans often overlook: an athlete can fail for a legitimate medical reason rather than cheating. Inam Butt's case is the clearest example I have tracked across years of reporting on disciplinary matters. Inam Butt is one of the rare names in beach wrestling — a discipline governed by United World Wrestling (UWW), yet with a far narrower competitive pyramid than Olympic freestyle or Greco-Roman. His 'former beach wrestling world champion' status carries genuine weight, but it exists inside a smaller competition pool with fewer elite athletes and even fewer international events. At an age described as 'veteran', Inam Butt is no longer only an athlete. He simultaneously serves as national squad coach for Pakistan, secretary of the Pakistan Wrestling Federation (PWF), and chairman of the Pakistan Olympic Association (POA) athletes commission. Three roles, one person. That is typical of smaller national federations where thin human resources force one individual to carry multiple duties. The case began when Inam Butt was hospitalised for an eye condition. The medication he used falls under WADA's prohibited list if no valid TUE is in place. He filed for an exemption — but not in time. The International Testing Agency (ITA), the body handling doping cases within the Olympic movement, took up the file and began its review. What stands out in this file is its legal architecture. Authorities accepted that the medication was for eye treatment, not performance enhancement. Sources indicate the ITA even granted permission for the medication over a one-year period. But as I often write when analysing officiating decisions: discipline is not punishment; discipline is a way of reading the match. In this case, the 'match' is not on the wrestling mat — it is between administrative procedure and filing deadlines. And in such a match, time is the most unpredictable opponent. Inam Butt's error was procedural, not ethical. He did not attempt to conceal, did not use the substance to boost performance, and showed no sign of an organised doping scheme. He simply failed to file his TUE in time. Under the anti-doping system, this is classified as negligence, not intent. The expected penalty reflects that classification: roughly a two-month suspension, backdated to April, when the sample was likely taken, coinciding with the Asian Beach Games. Such a short sanction, combined with retroactive application, signals the 'no significant fault or negligence' provision within the WADA Code. But there is a point most reports glide past: stripping the Asian Beach Games silver does not depend on whether the medication was therapeutic. That is a consequence of strict liability. Once a positive sample is established, the result tied to it is forfeited, regardless of the athlete's intent. This separates two tiers of decision. The first handles the degree of responsibility: short or long, backdated or not. The second handles competitive consequence: whether the medal still belongs to the athlete. Inam Butt may escape a heavy sanction at tier one — but he almost certainly loses the medal at tier two. There is a notable contradiction in existing reports. On one hand, sources say Inam Butt 'failed to secure the TUE in time'. On the other, the same sources say the ITA granted him permission for a one-year period. These two can only reconcile if the TUE was granted retroactively after the fact, or if the permission covered a different window or substance than the positive sample. With the ITA's formal decision not yet published, this is a detail to track rather than assume either side is wrong. The way media frames this case is striking. Headlines centre on 'relief in sight', treating the reduced sanction as the main news. But placed beside strict liability, the balanced picture is different. The silver may still be stripped, and his name still sits in an international doping file. Kazan erased a goal, but opened an eye. Here, Inam Butt's own eye — his eye condition — is what put him in a doping file. That reveals a blind spot in how the community understands anti-doping: athletes can lose not because they chose to cheat, but because they chose to treat an illness without being fully briefed on procedure. The core sources behind the case's 'leniency' are all anonymous. Until the ITA issues its formal ruling — expected within a week — any prediction about the sanction is just a prediction. Data never commits a foul; the writer is the one who gets carded. And here, the writer must lean on sources rather than a published judgment. Meanwhile, Inam Butt voluntarily stepped down from two posts: PWF secretary and POA athletes commission chairman. He said the move ensures impartiality during the process. This is a rare gesture in amateur sport. It shows awareness that a person who is simultaneously athlete, coach, and federation administrator cannot also be a defendant in a doping file without creating a conflict of interest. This opens a structural issue larger than the individual case: small federations often concentrate manpower in a few individuals because they lack people. That role concentration carries conflict-of-interest risk. And when crisis hits, it leaves a governance gap that immediate resignation cannot fill. Naming replacements at PWF and POA will be the next test of Pakistan's governance system. The question is not whether Inam Butt cheated. The question is whether the system has built an administrative trap for those who legitimately treat illness but lack TUE literacy — especially in countries where sports-medicine infrastructure is thin and athletes must navigate international paperwork alone. In recent years, doping adjudication in the Olympic movement has shifted from national federations toward independent bodies like the ITA. That trend reduces internal pressure risk and also reduces the chance a country 'shields' its own athlete. But it demands that athletes understand the process more than ever. If the ITA publishes its decision next week, a lenient sanction may match predictions. But even then, the silver may remain in the Asian Beach Games archive. For Inam Butt, the harder worry than losing a medal is having to prove both that he did not cheat and that he remains fit to lead a national squad. In sport, the price is sometimes not in the sanction, but in the things a sanction cannot give back.